ID   CAF17_HUMAN             Reviewed;         356 AA.
AC   Q5T440;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   18-JUN-2025, entry version 148.
DE   RecName: Full=Iron-sulfur cluster assembly factor IBA57, mitochondrial;
DE   AltName: Full=Iron-sulfur cluster assembly factor homolog;
DE   Flags: Precursor;
GN   Name=IBA57; Synonyms=C1orf69;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=22323289; DOI=10.1091/mbc.e11-09-0772;
RA   Sheftel A.D., Wilbrecht C., Stehling O., Niggemeyer B., Elsasser H.P.,
RA   Muhlenhoff U., Lill R.;
RT   "The human mitochondrial ISCA1, ISCA2, and IBA57 proteins are required for
RT   [4Fe-4S] protein maturation.";
RL   Mol. Biol. Cell 23:1157-1166(2012).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   INVOLVEMENT IN SPG74.
RX   PubMed=25609768; DOI=10.1212/wnl.0000000000001270;
RA   Lossos A., Stuempfig C., Stevanin G., Gaussen M., Zimmerman B.E.,
RA   Mundwiller E., Asulin M., Chamma L., Sheffer R., Misk A., Dotan S.,
RA   Gomori J.M., Ponger P., Brice A., Lerer I., Meiner V., Lill R.;
RT   "Fe/S protein assembly gene IBA57 mutation causes hereditary spastic
RT   paraplegia.";
RL   Neurology 84:659-667(2015).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [7]
RP   SUBUNIT, INTERACTION WITH ISCA2, AND MUTAGENESIS OF ARG-146.
RX   PubMed=31831856; DOI=10.1038/s41598-019-55313-5;
RA   Nasta V., Da Vela S., Gourdoupis S., Ciofi-Baffoni S., Svergun D.I.,
RA   Banci L.;
RT   "Structural properties of [2Fe-2S] ISCA2-IBA57: a complex of the
RT   mitochondrial iron-sulfur cluster assembly machinery.";
RL   Sci. Rep. 9:18986-18986(2019).
RN   [8]
RP   VARIANT MMDS3 PRO-314, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=23462291; DOI=10.1093/hmg/ddt107;
RA   Ajit Bolar N., Vanlander A.V., Wilbrecht C., Van der Aa N., Smet J.,
RA   De Paepe B., Vandeweyer G., Kooy F., Eyskens F., De Latter E., Delanghe G.,
RA   Govaert P., Leroy J.G., Loeys B., Lill R., Van Laer L., Van Coster R.;
RT   "Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe
RT   myopathy and encephalopathy.";
RL   Hum. Mol. Genet. 22:2590-2602(2013).
RN   [9] {ECO:0007744|PDB:6GEU}
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 43-356, INTERACTION WITH ISCA2,
RP   SUBUNIT, MUTAGENESIS OF CYS-259, AND FUNCTION.
RX   PubMed=30269484; DOI=10.1021/jacs.8b09061;
RA   Gourdoupis S., Nasta V., Calderone V., Ciofi-Baffoni S., Banci L.;
RT   "IBA57 Recruits ISCA2 to Form a [2Fe-2S] Cluster-Mediated Complex.";
RL   J. Am. Chem. Soc. 140:14401-14412(2018).
RN   [10] {ECO:0007744|PDB:6QE3, ECO:0007744|PDB:6QE4}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 44-352.
RX   PubMed=30950402; DOI=10.1107/s2059798319000214;
RA   Gourdoupis S., Nasta V., Ciofi-Baffoni S., Banci L., Calderone V.;
RT   "In-house high-energy-remote SAD phasing using the magic triangle: how to
RT   tackle the P1 low symmetry using multiple orientations of the same crystal
RT   of human IBA57 to increase the multiplicity.";
RL   Acta Crystallogr. D Struct. Biol. 75:317-324(2019).
CC   -!- FUNCTION: Mitochondrial protein involved in the maturation of
CC       mitochondrial [4Fe-4S]-proteins in the late stage of the iron-sulfur
CC       cluster assembly pathway (PubMed:22323289, PubMed:23462291). Operates
CC       in cooperation with ISCA2 in the maturation of [4Fe-4S] proteins
CC       (PubMed:30269484). {ECO:0000269|PubMed:22323289,
CC       ECO:0000269|PubMed:23462291, ECO:0000269|PubMed:30269484}.
CC   -!- FUNCTION: Involved in the maturation of mitochondrial 2Fe-2S proteins
CC       in the late stage of the iron-sulfur cluster assembly pathway.
CC       {ECO:0000269|PubMed:23462291}.
CC   -!- SUBUNIT: Monomer (PubMed:31831856). Heterotetramer; forms a dimer of
CC       dimers with ISCA2 (PubMed:31831856). Interacts with [2Fe-2S]-ISCA2
CC       forming the heterodimer [2Fe- 2S]-ISCA2-IBA57 complex; [2Fe-2S] cluster
CC       binding is absolutely required to promote the complex formation
CC       (PubMed:30269484). {ECO:0000269|PubMed:30269484,
CC       ECO:0000269|PubMed:31831856}.
CC   -!- INTERACTION:
CC       Q5T440; Q86U28: ISCA2; NbExp=6; IntAct=EBI-10714899, EBI-10258659;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:22323289,
CC       ECO:0000269|PubMed:23462291}.
CC   -!- TISSUE SPECIFICITY: Expressed in skin fibroblasts and skeletal muscle
CC       (at protein level). {ECO:0000269|PubMed:23462291}.
CC   -!- DISEASE: Multiple mitochondrial dysfunctions syndrome 3 (MMDS3)
CC       [MIM:615330]: A severe disorder of systemic energy metabolism,
CC       resulting in weakness, respiratory failure, lack of neurologic
CC       development, lactic acidosis, hyperglycinemia and early death. Some
CC       patients show failure to thrive, pulmonary hypertension, hypotonia and
CC       irritability. Biochemical features include severe combined deficiency
CC       of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and
CC       reduction in activity of mitochondrial respiratory chain complexes.
CC       {ECO:0000269|PubMed:23462291}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Spastic paraplegia 74, autosomal recessive (SPG74)
CC       [MIM:616451]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness and
CC       spasticity of the lower limbs. Rate of progression and the severity of
CC       symptoms are quite variable. Initial symptoms may include difficulty
CC       with balance, weakness and stiffness in the legs, muscle spasms, and
CC       dragging the toes when walking. In some forms of the disorder, bladder
CC       symptoms (such as incontinence) may appear, or the weakness and
CC       stiffness may spread to other parts of the body. SPG74 is characterized
CC       by a combination of spastic paraplegia, optic atrophy, and peripheral
CC       neuropathy with childhood-onset and slow progression into late
CC       adulthood. {ECO:0000269|PubMed:25609768}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the GcvT family. CAF17/IBA57 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL359510; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS31046.1; -.
DR   RefSeq; NP_001010867.1; NM_001010867.4.
DR   PDB; 6GEU; X-ray; 1.55 A; A=43-356.
DR   PDB; 6QE3; X-ray; 1.75 A; A=44-352.
DR   PDB; 6QE4; X-ray; 2.30 A; A=31-356.
DR   PDBsum; 6GEU; -.
DR   PDBsum; 6QE3; -.
DR   PDBsum; 6QE4; -.
DR   AlphaFoldDB; Q5T440; -.
DR   SASBDB; Q5T440; -.
DR   SMR; Q5T440; -.
DR   BioGRID; 128310; 94.
DR   ComplexPortal; CPX-2503; ISCA2-IBA57 mitochondrial iron-sulfur protein assembly complex.
DR   FunCoup; Q5T440; 1031.
DR   IntAct; Q5T440; 27.
DR   MINT; Q5T440; -.
DR   STRING; 9606.ENSP00000355672; -.
DR   GlyGen; Q5T440; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q5T440; -.
DR   PhosphoSitePlus; Q5T440; -.
DR   SwissPalm; Q5T440; -.
DR   BioMuta; IBA57; -.
DR   DMDM; 74744873; -.
DR   jPOST; Q5T440; -.
DR   MassIVE; Q5T440; -.
DR   PaxDb; 9606-ENSP00000355672; -.
DR   PeptideAtlas; Q5T440; -.
DR   ProteomicsDB; 64428; -.
DR   Pumba; Q5T440; -.
DR   Antibodypedia; 52265; 74 antibodies from 13 providers.
DR   DNASU; 200205; -.
DR   Ensembl; ENST00000366711.4; ENSP00000355672.3; ENSG00000181873.13.
DR   GeneID; 200205; -.
DR   KEGG; hsa:200205; -.
DR   MANE-Select; ENST00000366711.4; ENSP00000355672.3; NM_001010867.4; NP_001010867.1.
DR   UCSC; uc001hsl.5; human.
DR   AGR; HGNC:27302; -.
DR   CTD; 200205; -.
DR   DisGeNET; 200205; -.
DR   GeneCards; IBA57; -.
DR   HGNC; HGNC:27302; IBA57.
DR   HPA; ENSG00000181873; Low tissue specificity.
DR   MalaCards; IBA57; -.
DR   MIM; 615316; gene.
DR   MIM; 615330; phenotype.
DR   MIM; 616451; phenotype.
DR   OpenTargets; ENSG00000181873; -.
DR   Orphanet; 468661; Autosomal recessive spastic paraplegia type 74.
DR   Orphanet; 363424; Multiple mitochondrial dysfunctions syndrome type 3.
DR   VEuPathDB; HostDB:ENSG00000181873; -.
DR   eggNOG; KOG2929; Eukaryota.
DR   GeneTree; ENSGT00390000006465; -.
DR   HOGENOM; CLU_007884_7_1_1; -.
DR   InParanoid; Q5T440; -.
DR   OMA; MDRLHGV; -.
DR   OrthoDB; 191995at2759; -.
DR   PAN-GO; Q5T440; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q5T440; -.
DR   PathwayCommons; Q5T440; -.
DR   SignaLink; Q5T440; -.
DR   BioGRID-ORCS; 200205; 177 hits in 1164 CRISPR screens.
DR   ChiTaRS; IBA57; human.
DR   GenomeRNAi; 200205; -.
DR   Pharos; Q5T440; Tbio.
DR   PRO; PR:Q5T440; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5T440; protein.
DR   Bgee; ENSG00000181873; Expressed in pancreatic ductal cell and 171 other cell types or tissues.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006783; P:heme biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IBA:GO_Central.
DR   FunFam; 3.30.1360.120:FF:000015; IBA57, iron-sulfur cluster assembly; 1.
DR   Gene3D; 3.30.1360.120; Probable tRNA modification gtpase trme, domain 1; 1.
DR   InterPro; IPR027266; TrmE/GcvT_dom1.
DR   InterPro; IPR045179; YgfZ/GcvT.
DR   InterPro; IPR017703; YgfZ/GcvT_CS.
DR   NCBIfam; TIGR03317; ygfZ_signature; 1.
DR   PANTHER; PTHR22602; TRANSFERASE CAF17, MITOCHONDRIAL-RELATED; 1.
DR   PANTHER; PTHR22602:SF0; TRANSFERASE CAF17, MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF25455; Beta-barrel_CAF17_C; 1.
DR   SUPFAM; SSF103025; Folate-binding domain; 1.
DR   neXtProt; NX_Q5T440; -.
DR   PharmGKB; PA142672519; -.
DR   TreeFam; TF105983; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Disease variant; Heme biosynthesis;
KW   Hereditary spastic paraplegia; Mitochondrion; Neurodegeneration;
KW   Primary mitochondrial disease; Proteomics identification;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..39
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           40..356
FT                   /note="Iron-sulfur cluster assembly factor IBA57,
FT                   mitochondrial"
FT                   /id="PRO_0000278633"
FT   MOD_RES         309
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CAK1"
FT   MOD_RES         309
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CAK1"
FT   VARIANT         211
FT                   /note="G -> S (in dbSNP:rs2298014)"
FT                   /id="VAR_030794"
FT   VARIANT         314
FT                   /note="Q -> P (in MMDS3; loss of stability and consequently
FT                   decrease in various mitochondrial 4Fe-4S proteins and in
FT                   proteins covalently linked to lipoic acid;
FT                   dbSNP:rs587777016)"
FT                   /evidence="ECO:0000269|PubMed:23462291"
FT                   /id="VAR_069821"
FT   MUTAGEN         146
FT                   /note="R->A: Abolishes interaction with ISCA2."
FT                   /evidence="ECO:0000269|PubMed:31831856"
FT   MUTAGEN         259
FT                   /note="C->A: Abolishes the formation of the [2Fe-2S]
FT                   ISCA2-IBA57 complex formation."
FT                   /evidence="ECO:0000269|PubMed:30269484"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          56..63
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           66..71
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          91..100
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          106..129
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           133..143
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          150..153
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          157..166
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:6QE3"
FT   STRAND          178..187
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          196..202
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           216..226
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   TURN            232..234
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   TURN            237..239
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   TURN            242..246
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           247..249
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          255..257
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           263..272
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          276..284
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          298..301
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          306..314
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          317..323
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          327..329
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:6GEU"
FT   STRAND          336..339
FT                   /evidence="ECO:0007829|PDB:6QE4"
FT   STRAND          342..345
FT                   /evidence="ECO:0007829|PDB:6GEU"
SQ   SEQUENCE   356 AA;  38155 MW;  199A04DAB6840807 CRC64;
     MATAALLRGA TPGRGGPVWR WRLRAAPRCR LAHSSCSPGG DPTAGAAWAC FRLDGRTLLR
     VRGPDAAPFL LGLLTNELPL PSPAAAGAPP AARAGYAHFL NVQGRTLYDV ILYGLQEHSE
     VSGFLLECDS SVQGALQKHL ALYRIRRKVT VEPHPELRVW AVLPSSPEAC GAASLQERAG
     AAAILIRDPR TARMGWRLLT QDEGPALVPG GRLGDLWDYH QHRYLQGVPE GVRDLPPGVA
     LPLESNLAFM NGVSFTKGCY IGQELTARTH HMGVIRKRLF PVRFLDPLPT SGITPGATVL
     TASGQTVGKF RAGQGNVGLA LLWSEKIKGP LHIRASEGAQ VALAASVPDW WPTVSK
//
